中文 | English
Return
Total: 540 , 1/54
Show Home Prev Next End page: GO
Author:(Zhong-Yan ZHOU)

1.Study on the distribution of auto-antibodies against platelet in adults and children with primary immune thrombocytopenia in Nanning

Yan ZHOU ; Zhoulin ZHONG ; Jinlian LIU

International Journal of Laboratory Medicine 2015;(11):1500-1501,1504

4.Relevant factors for severe neurologic complications after coronary artery bypass grafting

Yiguang YAN ; Dongjin WANG ; Zhong WU ; Qingguo LI ; Qing ZHOU

Chinese Journal of Tissue Engineering Research 2010;14(18):3359-3362

5.Anti-tumor activities of CIK cells derived from lymph nodes of lung cancer patients

Jiajun TENG ; Yan ZHOU ; Xianxun LIU ; Baohui HAN ; Hua ZHONG

China Oncology 2015;(9):665-670

6.Effects of different implant methods on in vitro adhesion of tissue-engineered gingival cells

Daiqin ZHONG ; Qinhu ZHOU ; Chenxin JIN ; Yan LIANG

Chinese Journal of Tissue Engineering Research 2014;(21):3299-3303

7.Prognostic prediction of primary biliary cirrhosis and therapy monitoring with ursodeoxycholic acid

Yan LIANG ; Zaixing YANG ; Renqian ZHONG ; Lin ZHOU

Chinese Journal of Laboratory Medicine 2016;39(2):82-84

8.Therapeutic effect of clindamycin combined with compound sulfamethox-azole tablets on pneumocystis pneumonia associated with acquired immuno-deficiency syndrome

Zhong CHEN ; Gang XIAO ; Quan ZHOU ; Yan HE

Chinese Journal of Infection Control 2016;15(10):773-776

9.The single-center safety observation of ipilimumab combined with chemotherapy in the treatment of advanced squamous cell carcinoma

Zhangguo HU ; Yan ZHOU ; Xianxun LIU ; Baohui HAN ; Hua ZHONG

China Oncology 2017;27(1):31-35

10.The efficacy and safety of low-dose tiotropium bromide inhaled via Respimat(R) in patients with chronic obstructive pulmonary disease

Jinfang MA ; Zhimin ZHOU ; Yan TANG ; Nanshan ZHONG

Chinese Journal of Internal Medicine 2014;53(12):964-968

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 540 , 1/54 Show Home Prev Next End page: GO